Implantable injection port for long-term venous access.
In recent times, totally implantable devices using a Silastic right atrial catheter connected to a subcutaneous injection chamber have been introduced for long-term venous access. This study reports the experience of 39 patients in whom 41 such devices have been implanted. It totals 9697 patient days so far. There has been no incidence of major vein or catheter thrombosis and an infection rate of 0.41 per 1000 catheter days has been achieved. Catheter related complications have occurred in 20% of the cases after a mean duration of usage of 237 days. It is concluded that implantable injection ports provide a safe and reliable method of prolonged venous access.
Carmalt
H L
HL
Department of Surgery, Concord Hospital, New South Wales, Australia.
Duggan
D
D
D000328:Adult; D000368:Aged; D002405:Catheterization, Central Venous / Q000295:instrumentation*; D002408:Catheters, Indwelling / Q000009:adverse effects; D005260:Female; D006801:Humans; D007239:Infections / Q000453:epidemiology; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013924:Thrombophlebitis / Q000453:epidemiology